Rapamycin Target Eluting Stent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rapamycin Target Eluting Stent, covering 2025-04-13 to 2025-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atherosclerotic Disease（TARGET-DREAM） [Phase 3]